NEOS THERAPEUTICS INC's ticker is NEOS and the CUSIP is 64052L106. A total of 84 filers reported holding NEOS THERAPEUTICS INC in Q4 2017. The put-call ratio across all filers is 0.23 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2018 | $2,744,000 | -59.3% | 330,576 | -50.0% | 0.57% | -85.3% |
Q4 2017 | $6,743,000 | -29.4% | 661,045 | -36.7% | 3.91% | +28.5% |
Q3 2017 | $9,550,000 | +25.3% | 1,043,770 | 0.0% | 3.04% | +21.3% |
Q2 2017 | $7,620,000 | +1.4% | 1,043,770 | 0.0% | 2.51% | -51.0% |
Q1 2017 | $7,515,000 | +85.2% | 1,043,770 | +50.5% | 5.12% | +122.6% |
Q4 2016 | $4,057,000 | -21.4% | 693,582 | -11.6% | 2.30% | -26.6% |
Q3 2016 | $5,163,000 | -19.8% | 784,704 | +13.1% | 3.14% | -22.5% |
Q2 2016 | $6,436,000 | -14.0% | 693,582 | 0.0% | 4.05% | -8.9% |
Q1 2016 | $7,484,000 | -42.9% | 693,582 | -26.1% | 4.44% | -35.1% |
Q4 2015 | $13,105,000 | -26.4% | 938,598 | 0.0% | 6.84% | -20.8% |
Q3 2015 | $17,813,000 | – | 938,598 | – | 8.65% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
DSC Advisors, L.P. | 938,598 | $13,105,000 | 6.84% |
Sio Capital Management, LLC | 781,514 | $11,191,000 | 4.96% |
DAFNA Capital Management LLC | 63,400 | $908,000 | 0.81% |
WALL STREET ASSOCIATES | 149,343 | $2,139,000 | 0.60% |
EMERALD MUTUAL FUND ADVISERS TRUST | 412,058 | $5,901,000 | 0.31% |
NEXTHERA CAPITAL LP | 15,000 | $215,000 | 0.30% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 458,332 | $6,563,000 | 0.27% |
EMERALD ADVISERS, LLC | 378,874 | $5,425,000 | 0.26% |
Perceptive Advisors | 142,603 | $2,042,000 | 0.15% |
Cormorant Asset Management, LP | 50,000 | $716,000 | 0.09% |